Your browser doesn't support javascript.
loading
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
Hiraoka, Atsushi; Kumada, Takashi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Ohama, Hideko; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Joko, Kouji; Iijima, Hiroko; Hiasa, Yoichi; Kudo, Masatoshi.
Afiliação
  • Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Kasuga-cho, Ehime, Japan.
  • Kumada T; Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
  • Tada T; Department of Internal Medicine, Himeji Red Cross Hospital, Hyogo, Japan.
  • Hirooka M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Kariyama K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Tani J; Department of Gastroenterology and Hepatology, Kagawa University, Kagawa, Japan.
  • Atsukawa M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Takaguchi K; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Itobayashi E; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan.
  • Fukunishi S; Department of Gastroenterology, Osaka Medical College, Osaka, Japan.
  • Tsuji K; Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Ishikawa T; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
  • Tajiri K; Department of Gastroenterology, Toyama University Hospital, Toyama, Japan.
  • Ochi H; Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Yasuda S; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan.
  • Toyoda H; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan.
  • Ogawa C; Department of Gastroenterology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
  • Nishimura T; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Hatanaka T; Department of Gastroenterology and Hepatology, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Ohama H; Department of Gastroenterology, Osaka Medical College, Osaka, Japan.
  • Nouso K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Morishita A; Department of Gastroenterology and Hepatology, Kagawa University, Kagawa, Japan.
  • Tsutsui A; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Nagano T; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • Itokawa N; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Okubo T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Arai T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Imai M; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
  • Koizumi Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Nakamura S; Department of Internal Medicine, Himeji Red Cross Hospital, Hyogo, Japan.
  • Joko K; Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Iijima H; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Hiasa Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University, Osaka, Japan.
Cancer Rep (Hoboken) ; 5(2): e1464, 2022 02.
Article em En | MEDLINE | ID: mdl-34114752
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Bevacizumab / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Cancer Rep (Hoboken) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Bevacizumab / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Cancer Rep (Hoboken) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos